# Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts

> **NCT04652648** · PHASE4 · COMPLETED · sponsor: **Bryn Mawr Hospital** · enrollment: 54 (actual)

## Conditions studied

- Covid19
- Hydroxychloroquine
- Coronavirus Infection
- Transmission
- Prophylaxis

## Interventions

- **DRUG:** Hydroxychloroquine

## Key facts

- **NCT ID:** NCT04652648
- **Lead sponsor:** Bryn Mawr Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-27
- **Primary completion:** 2020-10-31
- **Final completion:** 2020-11-15
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2020-12-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04652648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04652648, "Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04652648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*